ReviewInternational journal of nanomedicine2026
Application and Advances of Cell Membrane-Coated Nanoparticles in Diabetic Wound Healing.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nature-Inspired Alternatives to PEG for Next-Generation Long-Circulating Nanocarriers.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wound healing in diabetes is a complicated and challenging task, which is affected by many factors. For example, microcirculatory disorders, inflammatory reactions, cell signaling disruption, abnormal fibrosis, and impaired immunity due to high blood sugar may have an adverse effect on wound healing. In order to address this problem, researchers have continued to explore a broad range of innovative approaches. Nanoparticles, as a novel repair material, are widely used due to their unique physical and chemical properties, particularly in the treatment of diabetes; however, they also have certain limitations. Cell membrane-coated nanoparticles, with their inherent biocompatibility and precise drug delivery capabilities, have emerged as a novel and highly effective strategy for treating diabetic wounds. Among these, nanoparticles coated with macrophage membranes and mesenchymal stem cell membranes have demonstrated the most significant therapeutic effects in wound anti-inflammation, vascular regeneration, and tissue repair. They can effectively improve the local pathological microenvironment, offering a novel and highly effective nanotherapeutic strategy for the treatment of chronic wounds. This paper systematically reviews research progress on nanoparticles coated with red blood cell membranes, macrophage membranes, stem cell membranes, and exosome membranes for treating diabetic wounds. It comprehensively organizes findings based on membrane source classification, mechanisms of action and in vitro/in vivo evidence. Compared to existing reviews, this paper's primary innovations and contributions lie in establishing a comprehensive membrane classification system, deeply analyzing the synergistic logic of multi-mechanism actions, and it provides a comprehensive analysis of practical challenges in areas such as reproducibility, safety, immunomodulation, large-scale production, regulatory compliance, and clinical translation. It provides theoretical support and practical references for developing more precise and safer wound repair strategies in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.